Non-Hodgkin Lymphoma (NHL) Treatment Regimens: AIDS-Related B-Cell Lymphoma
View a treatment regimen chart for AIDS-related B-cell lymphoma, with detailed information based on condition (ie, Burkitt lyphoma, Castleman’s Disease).
HIV/AIDS
Non-Hodgkin Lymphoma (NHL) Treatment Regimens: AIDS-Related B-Cell Lymphoma
View a treatment regimen chart for AIDS-related B-cell lymphoma, with detailed information based on condition (ie, Burkitt lyphoma, Castleman’s Disease).
Non-Hodgkin Lymphoma (NHL) Treatment Regimens: AIDS-Related B-Cell Lymphoma
View a treatment regimen chart for AIDS-related B-cell lymphoma, with detailed information based on condition (ie, Burkitt lyphoma, Castleman’s Disease).
Variation seen in number of cancer survivors undergoing HIV testing
Proportion undergoing testing varies by demographic and health-related factors, and by state, a study found.
Only 41% of cancer survivors tested for HIV
Only 41% of cancer survivors in the U.S. under 65 reported ever having a human immunodeficiency virus (HIV) test.
Steroids used for HIV-associated tuberculosis increase cancer risk
Adding steroids for the treatment of tuberculosis pericarditis in patients co-infected with HIV may increase the risk of cancer.
HIV-positive patients are more likely to be untreated for early-stage cancer
HIV-infected people with early stage cancer are two to four times more likely to go untreated for their cancer compared to uninfected patients with cancer, according to a new, large retrospective study.
Those with HIV less likely to receive cancer treatment
HIV-infected individuals with cancer are less likely to receive treatment, according to a study published online in the Journal of Clinical Oncology.
For patients with AIDS-related lymphomas, identification of CNS involvement at diagnosis does not affect overall survival
Patients with AIDS-related lymphomas may face an increased risk of CNSi compared to other lymphomas. Researchers report that CNSi – identified at the time of an ARL diagnosis – does not appear to have an impact on overall survival. The vast majority of patients have stage IV disease at the time of presentation.
Potential treatment for deadly HIV-related blood cancer
Researchers have discovered a promising new way to treat a rare and aggressive blood cancer that is most commonly found in people infected with HIV.
